CNTB logo

CNTB Connect Biopharma Holdings Limited

NASDAQ Global Market · Biotechnology · Healthcare

$0.63
-0.04 (-5.56%)

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb cl…

Market Cap: $40.51Mwww.connectbiopharma.com

Price

No data yet.

Social Signal Score

50
5d
—
30d
50
1 mentions
—
60d
48
7 mentions
—
90d
51
9 mentions
—
news: 9

Analyst Ratings

7 analysts
Buyconsensus
Strong Buy 0Buy 7Hold 0Sell 0Strong Sell 0
Avg price target$6.6+950.6%
Low $4Median $7High $8
Current Consensus

Revenue

$0.00
$0.00$8.04M$16.08M$24.12M
Jun 2019Sep 2026

Analyst Estimates

FY2025
$-1.01
$-1.03–$-0.99
4 analysts
FY2026
$-1.01
$-1.13–$-0.86
5 analysts
FY2027
$-0.68
$-1.01–$-0.50
5 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Barry D. Quart
Sector
Healthcare
Industry
Biotechnology
Employees
64
Beta
-0.22
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-24.88
www.connectbiopharma.com